Interpreting the Health Care Law

The Democratic chairmen of the House and Senate committees that oversaw health reform weighed in this week on an arguably small matter of how the new law was being shaped. But the intrusion has some big implications, not only for what it means to the question at hand, but its foreshadowing of the very political context in which regulatory decisions implementing the new law are likely to be made.

The letter turned on the question of the "legislative intent" when crafting a definition of the federal taxes that could be excluded from calculating the medical loss ratio that insurers will be held to. At issue is a part of the new health law that fixes how much insurers must spend on medical benefits versus administrative costs. The law says that "federal and state taxes and licensing or regulatory fees . . ." should be excluded from the premium revenue number, or the MLR denominator, and thus essentially counted as medical costs.

The new definition will leave insurers even more capital constrained--something that would appear to be a self-defeating exercise for Democrats at this stage in the game.

Earlier this month, an independent group advising HHS gravitated toward a definition that would exclude from the MLR denominator all money spent on federal taxes, save taxes paid on investment gains. The congressional letter--sent to the HHS secretary--says not so fast. The drafters meant to include both federal income taxes and payroll taxes in the denominator of the MLR calculation.

In effect, this means insurers would have to spend even more money on medical expenses to offset every dollar they spend on administrative costs, since the money paid on taxes would now be part of the total pie.

Insurers say this interpretation doesn't follow the plain language of the law and plan to make it a major issue. Regardless, the new definition will leave insurers even more capital constrained--something that would appear to be a self-defeating exercise for Democrats at this stage in the game. After all, the new law already gives Democrats plenty of leverage over insurers, effectively nationalizing the regulation of health insurance and saddling the industry with new mandates, fees, and taxes.

Sticking it to the plans still further doesn't seem to accomplish much additional.

Scott Gottlieb, M.D., is a resident fellow at AEI.

Photo Credit: Tom Grill/Corbis

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Scott
Gottlieb
  • Scott Gottlieb, M.D., a practicing physician, has served in various capacities at the Food and Drug Administration, including senior adviser for medical technology; director of medical policy development; and, most recently, deputy commissioner for medical and scientific affairs. Dr. Gottlieb has also served as a senior policy adviser at the Centers for Medicare & Medicaid Services. 

    Click here to read Scott’s Medical Innovation blog.


    Follow Scott Gottlieb on Twitter.

  • Phone: 202-862-5885
    Email: scott.gottlieb@aei.org
  • Assistant Info

    Name: Catherine Griffin
    Phone: 2028625920
    Email: catherine.griffin@aei.org

What's new on AEI

image The Pentagon’s illusion of choice: Hagel’s 2 options are really 1
image Wild about Larry
image Primary care as affordable luxury
image Solving the chicken-or-egg job problem
AEI on Facebook
Events Calendar
  • 05
    MON
  • 06
    TUE
  • 07
    WED
  • 08
    THU
  • 09
    FRI
Tuesday, August 06, 2013 | 12:00 p.m. – 1:30 p.m.
Uniting universal coverage and personal choice: A new direction for health reform

Join some of the authors, along with notable health scholars from the left and right, for the release of “Best of Both Worlds: Uniting Universal Coverage and Personal Choice in Health Care,” and a new debate over the priorities and policies that will most effectively reform health care.

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.